Misoprostol-Only Medication Abortion Regimen

Political Climate After the U.S. Supreme Court’s decision to eliminate the constitutional protections for abortion in Dobbs v. Jackson Women’s Health Organization in June 2022, access to mifepristone and abortion services in general are being threatened across the country. An ongoing anti-abortion lawsuit in Texas seeks to reverse mifepristone’s FDA approval and remove it from…

Read More

Upcoming Changes to the Mifepristone REMS Program: Implications for Pharmacy Practice

Pharmacists in the community setting may soon have the opportunity to ease access to medication abortion in the United States. In the coming months, mifepristone (Mifeprex) is anticipated to have an updated Risk Evaluation and Mitigation Strategy (REMS) Program that allows dispensing through local brick-and-mortar and mail-order pharmacies. This change will integrate pharmacists into abortion…

Read More